Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

Healthcare Biotechnology

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

CSE:PREV - Post by User

Preveceutical Medical Inc

Bullboard Posts

Comment by CanadaCoinon Apr 04, 2019 8:17pm

80 Views

Post# 29585163

RE:RE:What we know

Moneyman711 wrote: https://ceo.ca/@newsfile/preveceutical-announces-loi-with-crushedit-llc-to-supply

16 million guaranteed revenue and we are only worth 21 million!! What do you guys think a proper market cap for us should be. I'm saying 40-55 million depending on a lot of variables.

Are you referring to the....'non-binding'....'letter of intent'....'that has not closed'? [re: press release of Nov 13th, 2018]

Are you not aware that PREV has 600 million shares fully diluted....and climbing?

Your $50 million target, divided by 600 million shares = $0.08/share. You may very get your wish tomorrow. :)

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal